Louisiana State Employees Retirement System raised its position in shares of Ingevity Co. (NYSE:NGVT – Free Report) by 3.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,600 shares of the company’s stock after purchasing an additional 600 shares during the period. Louisiana State Employees Retirement System’s holdings in Ingevity were worth $686,000 as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in NGVT. First Horizon Advisors Inc. boosted its holdings in shares of Ingevity by 809.2% during the 2nd quarter. First Horizon Advisors Inc. now owns 591 shares of the company’s stock worth $26,000 after buying an additional 526 shares during the period. Isthmus Partners LLC acquired a new stake in shares of Ingevity in the second quarter valued at about $35,000. Blue Trust Inc. increased its stake in shares of Ingevity by 101.8% in the second quarter. Blue Trust Inc. now owns 896 shares of the company’s stock worth $43,000 after purchasing an additional 452 shares during the period. Headlands Technologies LLC bought a new position in shares of Ingevity in the second quarter worth about $46,000. Finally, nVerses Capital LLC acquired a new position in shares of Ingevity during the 3rd quarter worth about $113,000. 91.59% of the stock is currently owned by institutional investors and hedge funds.
Ingevity Stock Down 0.2 %
Shares of NYSE NGVT opened at $41.92 on Tuesday. The business has a fifty day moving average of $36.96 and a two-hundred day moving average of $42.36. The company has a debt-to-equity ratio of 6.52, a quick ratio of 1.07 and a current ratio of 1.76. Ingevity Co. has a 52-week low of $30.90 and a 52-week high of $56.29. The stock has a market cap of $1.52 billion, a PE ratio of -2.70 and a beta of 1.60.
Analysts Set New Price Targets
Several research analysts have commented on NGVT shares. Wells Fargo & Company dropped their price target on Ingevity from $45.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Monday, August 5th. BMO Capital Markets boosted their target price on shares of Ingevity from $40.00 to $47.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Oppenheimer reduced their price target on shares of Ingevity from $58.00 to $50.00 and set an “outperform” rating for the company in a report on Thursday, August 1st. Finally, CJS Securities raised shares of Ingevity from a “market perform” rating to an “outperform” rating and set a $58.00 price objective for the company in a research report on Wednesday, August 7th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Ingevity presently has an average rating of “Moderate Buy” and a consensus target price of $52.17.
Get Our Latest Research Report on NGVT
Ingevity Profile
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
See Also
- Five stocks we like better than Ingevity
- Conference Calls and Individual Investors
- Intel: Is Now the Time to Be Brave?Â
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Find Undervalued Stocks
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.